Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity
|
April 4, 2024
Prevalence of obesity in religious clergy in the United States: A systematic review and meta-analysis
David Eagle, Anna Holleman, Brianda Barrera Olvera, et al.
Health Law in Canada
|
November 7, 2007
Gender, diversity and evidence-based decision-making
Olena Hankivsky, Elizabeth Blackwood, Rodney Hunt, et al.
Molecular Cancer Therapeutics
|
February 1, 2017
Ras-MEK Signaling Mediates a Critical Chk1-Dependent DNA Damage Response in Cancer Cells
Ho-June Lee, Yi Cao, Victoria Pham, et al.
Molecular Cancer Therapeutics
|
September 17, 2013
Identification of preferred chemotherapeutics for combining with a CHK1 inhibitor
Yang Xiao, Judi Ramiscal, Kaska Kowanetz, et al.
Nature Communications
|
November 23, 2017
The combination of CHK1 inhibitor with G-CSF overrides cytarabine resistance in human acute myeloid leukemia
Alessandro Di Tullio, Kevin Rouault-Pierre, Ander Abarrategi, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 20, 2025
HIV, HPV, AND ORAL HEALTH IN TANZANIA: A SCOPING REVIEW
Kalipa Gedion, Elizabeth Blackwood, Judith Mwobobia, et al.
Science Signaling
|
April 18, 2013
Phosphoproteomic analysis implicates the mTORC2-FoxO1 axis in VEGF signaling and feedback activation of receptor tyrosine kinases
Guanglei Zhuang, Kebing Yu, Zhaoshi Jiang, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery
|
September 30, 2025
Overview of pediatric hydrocephalus in Nigeria: A systematic review
Sean C Holden-Kapshuck, Temitayo O Ayantayo, Amos O Adeleye, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
September 8, 2012
Toxicity profile of small-molecule IAP antagonist GDC-0152 is linked to TNF-α pharmacology
Rebecca I Erickson, Jacqueline Tarrant, Gary Cain, et al.
Molecular Cancer Therapeutics
|
July 23, 2013
Combination drug scheduling defines a "window of opportunity" for chemopotentiation of gemcitabine by an orally bioavailable, selective ChK1 inhibitor, GNE-900
Elizabeth Blackwood, Jennifer Epler, Ivana Yen, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity
|
April 4, 2024
Prevalence of obesity in religious clergy in the United States: A systematic review and meta-analysis
David Eagle, Anna Holleman, Brianda Barrera Olvera, et al.
Health Law in Canada
|
November 7, 2007
Gender, diversity and evidence-based decision-making
Olena Hankivsky, Elizabeth Blackwood, Rodney Hunt, et al.
Molecular Cancer Therapeutics
|
February 1, 2017
Ras-MEK Signaling Mediates a Critical Chk1-Dependent DNA Damage Response in Cancer Cells
Ho-June Lee, Yi Cao, Victoria Pham, et al.
Molecular Cancer Therapeutics
|
September 17, 2013
Identification of preferred chemotherapeutics for combining with a CHK1 inhibitor
Yang Xiao, Judi Ramiscal, Kaska Kowanetz, et al.
Nature Communications
|
November 23, 2017
The combination of CHK1 inhibitor with G-CSF overrides cytarabine resistance in human acute myeloid leukemia
Alessandro Di Tullio, Kevin Rouault-Pierre, Ander Abarrategi, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 20, 2025
HIV, HPV, AND ORAL HEALTH IN TANZANIA: A SCOPING REVIEW
Kalipa Gedion, Elizabeth Blackwood, Judith Mwobobia, et al.
Science Signaling
|
April 18, 2013
Phosphoproteomic analysis implicates the mTORC2-FoxO1 axis in VEGF signaling and feedback activation of receptor tyrosine kinases
Guanglei Zhuang, Kebing Yu, Zhaoshi Jiang, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery
|
September 30, 2025
Overview of pediatric hydrocephalus in Nigeria: A systematic review
Sean C Holden-Kapshuck, Temitayo O Ayantayo, Amos O Adeleye, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
September 8, 2012
Toxicity profile of small-molecule IAP antagonist GDC-0152 is linked to TNF-α pharmacology
Rebecca I Erickson, Jacqueline Tarrant, Gary Cain, et al.
Molecular Cancer Therapeutics
|
July 23, 2013
Combination drug scheduling defines a "window of opportunity" for chemopotentiation of gemcitabine by an orally bioavailable, selective ChK1 inhibitor, GNE-900
Elizabeth Blackwood, Jennifer Epler, Ivana Yen, et al.
Page
of 3